CVS Health Corporation (NYSE: CVS) is listed among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company’s stock has surged by over 43% since the start of 2025, with revenues hitting $94.6 billion in the first quarter, showing a 7% growth from the same period last year. CVS also boasts a dividend yield of 4.20%.

Read more at Yahoo Finance: Can the Retail-Pharma Giant Deliver in 2025?